Yogatel-AM 40mg/5mg Tablet is a combination antihypertensive medication containing Telmisartan 40mg and Amlodipine 5mg, indicated for the management of hypertension. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, leading to decreased blood pressure. Amlodipine, a dihydropyridine calcium channel blocker, inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, promoting vasodilation and reducing peripheral vascular resistance. The synergistic action of these agents provides effective blood pressure control, minimizing the risk of cardiovascular events such as stroke and myocardial infarction. Yogatel-AM is particularly beneficial in patients who require combination therapy for optimal blood pressure management or those inadequately controlled on monotherapy. The tablet is administered orally once daily, with or without food, and dosage adjustments should be individualized based on clinical response and tolerability. Common adverse effects may include dizziness, peripheral edema, headache, and fatigue. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in pregnancy and patients with hypersensitivity to any component. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy.